Cerena Chen
Stock Analyst at Wells Fargo
(2.74)
# 1,780
Out of 5,163 analysts
5
Total ratings
75%
Success rate
24.11%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $139.67 | -61.34% | 1 | Sep 30, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $18.18 | +92.52% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $156.08 | +5.72% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $139.67
Upside: -61.34%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $18.18
Upside: +92.52%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $156.08
Upside: +5.72%